Literature DB >> 6980238

Neonatal screening for 21-hydroxylase deficiency: a microfilter paper method for 17-alpha-hydroxyprogesterone assay.

S Piazzi, M Capelli, M Paolini, D Perugini, G Grossi, A Balsamo, P Salomoni, A Cassio, G Bugiardini, E Cacciari.   

Abstract

A micromethod for measuring 17 alpha-hydroxyprogesterone in blood collected on filter paper has been developed. Our method is rapid, easy and has the specificity, accuracy and precision of the radioimmunoassay in whole blood. The method has been applied for screening patients with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. Fifty samples collected on filter paper were assayed by our method, using 125I as tracer, and results were compared with those obtained for the same samples using a tritium tracer. The agreement between the two methods was particularly good in the area ranging from 15 to 100 pg/disc. In one neonate the diagnosis of CAH was made utilizing the microfilter paper method. Our method is a promising screening test for CAH. An indication of the advantages or disadvantages of this type of screening will become available when an adequate number of infants has been examined.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6980238     DOI: 10.1007/BF03350496

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  13 in total

1.  [On the genetics of the congenital adrenogenital syndrome (virilizing adrenal hyperplasia)].

Authors:  A PRADER; G J ANDERS; H HABICH
Journal:  Helv Paediatr Acta       Date:  1962

2.  The adrenogenital syndrome.

Authors:  A M BONGIOVANNI; A W ROOT
Journal:  N Engl J Med       Date:  1963-06-06       Impact factor: 91.245

3.  Microfilter paper method for 17 alpha-hydroxyprogesterone radioimmunoassay: its application for rapid screening for congenital adrenal hyperplasia.

Authors:  S Pang; J Hotchkiss; A L Drash; L S Levine; M I New
Journal:  J Clin Endocrinol Metab       Date:  1977-11       Impact factor: 5.958

Review 4.  Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a review of current knowledge.

Authors:  G E Bacon; R P Kelch
Journal:  J Endocrinol Invest       Date:  1979 Jan-Mar       Impact factor: 4.256

5.  Serum 17-alpha-hydroxyprogesterone, progesterone, estradiol, and testosterone in the diagnosis and management of congenital adrenal hyperplasia.

Authors:  B M Lippe; S H LaFranchi; N Lavin; A Parlow; J Coyotupa; S A Kaplan
Journal:  J Pediatr       Date:  1974-12       Impact factor: 4.406

6.  Studies on the deficiency of 21-hydroxylation in patients with congenital adrenal hyperplasia.

Authors:  A P Simpoulos; J R Marshall; C S Delea; F C Bartter
Journal:  J Clin Endocrinol Metab       Date:  1971-03       Impact factor: 5.958

7.  Difficulties in the diagnosis of the adrenogenital syndrome in infancy.

Authors:  C H Shackleton; F L Mitchell; J W Farquhar
Journal:  Pediatrics       Date:  1972-02       Impact factor: 7.124

8.  Incidence of salt-losing form of congenital virilizing adrenal hyperplasia.

Authors:  Q H Qazi; M W Thompson
Journal:  Arch Dis Child       Date:  1972-04       Impact factor: 3.791

9.  An unusually high incidence of salt-losing congenital adrenal hyperplasia in the Alaskan Eskimo.

Authors:  A J Hirschfeld; J K Fleshman
Journal:  J Pediatr       Date:  1969-09       Impact factor: 4.406

10.  Prenatal diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  A Milunsky; D Tulchinsky
Journal:  Pediatrics       Date:  1977-05       Impact factor: 7.124

View more
  3 in total

1.  Neonatal screening programme for congenital adrenal hyperplasia in a homogeneous Caucasian population.

Authors:  E Cacciari; A Balsamo; A Cassio; S Piazzi; F Bernardi; S Salardi; A Cicognani; P Pirazzoli; F Zappulla; M Capelli
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

2.  Neonatal screening for congenital adrenal hyperplasia.

Authors:  E Cacciari; A Balsamo; A Cassio; S Piazzi; F Bernardi; S Salardi; A Cicognani; P Pirazzoli; F Zappulla; M Capelli
Journal:  Arch Dis Child       Date:  1983-10       Impact factor: 3.791

3.  Influence of spironolactone on neonatal screening for congenital adrenal hyperplasia.

Authors:  I Terai; K Yamano; N Ichihara; J Arai; K Kobayashi
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-11       Impact factor: 5.747

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.